Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.95 and traded as low as $1.9501. Evotec shares last traded at $1.96, with a volume of 50,289 shares changing hands.
Evotec Price Performance
The company’s 50 day simple moving average is $2.63 and its 200 day simple moving average is $2.95. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The stock has a market cap of $647.23 million, a P/E ratio of 4.78 and a beta of 0.98.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Read More
- Five stocks we like better than Evotec
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
